Canopy Growth has streamlined its portfolio through divestitures, focusing on becoming an asset-light, cannabis-centric ...

will present at the Piper Sandler Global Exchange and Trading Conference in New York City on Wednesday, June 5 at 2:00 p.m.

Piper Sandler initiated coverage of several biotech stocks in a note Friday, with all, barring one, being assigned Overweight ratings. ACLX was highlighted as having a potentially differentiated ...

A bipartisan Senate group last week recommended tens of billions of dollars in new federal spending to ensure the safe ...

In a report released today, Allison Bratzel from Piper Sandler maintained a Buy rating on Roivant Sciences (ROIV – Research Report), with a price target of $20.00. The company’s shares closed ...

Asana's (NYSE:ASAN) stock surged about 14% premarket on Friday after first-quarter results beat estimates and Piper Sandler ...

Fintel reports that on May 31, 2024, Piper Sandler initiated coverage of Elevation Oncology (NasdaqGS:ELEV) with a Overweight ...

The stock’s shares have broken out from a “double-bottom” formation and its relative strength has climbed to multi-month highs, said Analyst Craig W. Johnson, who recommends adding to positions “as we ...

With the 2024 US Presidential election approaching, Piper Sandler has examined how market perceptions of the outcome are ...

NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’), a diversified global financial services ...

On Monday, Piper Sandler adjusted its outlook on Myriad Genetics (NASDAQ:MYGN), increasing the stock's price target to $28 from $23, while sustaining an Overweight rating. The firm's analyst cited ...

Biotech stocks are naturally an exciting area for investment. Just one therapeutic breakthrough can change the whole ...